WEIGHT loss jabs slash alcohol cravings and can curb dangerous binge drinking, new research suggests.  The active drug ...

The patent refers to the Company’s innovative combination therapy of MEAI and N-Acylethanolamines, addressing binge behavior, including alcohol consumption, eating, tobacco consumption ...

Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to ...

addressing binge behaviour, including alcohol consumption, eating, tobacco consumption, shopping and sexual conduct. Under this collaboration, the two companies are researching innovative ...

The patent refers to the Company’s combination therapy of MEAI and N-Acylethanolamines, addressing binge behavior, including alcohol consumption, eating, tobacco consumption, shopping and sexual ...

This innovative system adapts treatment plans in real-time by analysing individual patient responses during trials, leading to more precise and effective healthcare outcomes. Ghosh said ...

Patients taking a commonly used stimulant for the treatment of binge eating disorder experienced mixed results, according to Rutgers Health researchers. Lisdexamfetamine, marketed as Vyvanse, first ...

The patent refers to SciSparc's innovative combination therapy of N-Acylethanolamines and Clearmind's MEAI, (5-methoxy-2-aminoindane) addressing binge behaviour, including alcohol consumption, eating, ...

The patent refers to the Company’s innovative combination therapy of MEAI and N-Acylethanolamines, addressing binge behavior, including alcohol consumption, eating, tobacco consumption, shopping and ...

Patients taking a commonly used stimulant for the treatment of binge eating disorder experienced mixed results, according to Rutgers Health researchers. "Binge eating disorder is the most common ...

Patients taking a commonly used stimulant for the treatment of binge eating disorder experienced mixed results, according to Rutgers Health researchers. Lisdexamfetamine, marketed as Vyvanse ...

Findings shed light on the dual-sided experiences of people using lisdexamfetamine, highlighting the perceived benefits and challenges of the drug Patients taking a commonly used stimulant for the ...